You have landed on a page of the archived Cochrane Community website. This site is not being maintained or updated.

If you are looking for Cochrane Review evidence, please visit Cochrane’s evidence page.

If you are a Cochrane contributor looking for Community resources, please visit the new Cochrane Community website.

Randomised controlled trials using invasive ‘placebo’ controls are unethical and should be excluded from Cochrane Reviews

Warning: Parameter 2 to onepixelout_swftools_flashvars() expected to be a reference, value given in module_invoke() (line 476 of /var/www/archive/includes/

To browse Podcasts by topic, please visit the new Cochrane Summaries site here

The use of invasive placebo controls in clinical trials is a contentious issue. In an editorial published in the June issue of The Cochrane Library, Allan Cyna and colleagues from the University of Adelaide in South Australia, describe why they think trials using invasive placebos should be excluded from Cochrane Reviews. This editorial is read by Rachel Marshall at the Cochrane Editorial Unit on behalf of the authors.

Read the Editorial here

Play Now!

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

Download [mp3]
Updated on: July 21, 2011, 14:27

Comments for improvement or correction are welcome.